TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years
The Global Alliance for TB Drug Development (TB Alliance) has...
Director-General, Forestry Research Institute of Nigeria (FRIN), Prof. Zacharia Yaduma, says Nigeria is strengthening policy and legal frameworks to...